MON-002

N/A

Report date: 2024/11/25 20:00:28

Base Information

Drug NameMON-002
Drug Alias NameMON-002MON002
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapy > Monocyte cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary FibrosisLung Diseases, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGuy'S And St Thomas' Nhs Foundation TrustKing'S College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKing'S College LondonGuy'S And St Thomas' Nhs Foundation Trust
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary FibrosisLung Diseases, Interstitial

Other Information

ATC CodeN/A
Related LinksN/A